期刊
CLINICAL BIOCHEMISTRY
卷 42, 期 13-14, 页码 1490-1492出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2009.06.004
关键词
Cardiovascular disease; Inflammation; Myeloperoxidase; Plasma; Serum
Objectives: To examine the effect of blood anticoagulation type on the myeloperoxidase (MPO) concentration. Design and methods: MPO was measured in EDTA-plasma and matched heparin-plasma and serum samples collected from healthy volunteers. Results: MPO concentrations in heparin-plasma and serum were higher than in EDTA-plasma (both P < 0.001). MPO in EDTA-plasma was not significantly correlated with MPO in either heparin-plasma or serum. Conclusions: For MPO measurements, EDTA-plasma is the preferred specimen as it appears unaffected by ex vivo release of MPO from leukocytes. (C) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据